 |
 |
|
|
 |
|
Acorda Therapeutics, Inc.
Acorda
Therapeutics, Inc. develops therapeutic products for spinal cord injury
("SCI") and other central nervous system disorders such
as multiple sclerosis (MS). Acorda is focusing its initial development
efforts on a range of therapeutics for individuals with chronic, or
long term, SCI. Currently, there is no therapy that improves neurological
function in chronic SCI patients.
Co-Investors: MDS, MPM, Easton Hunt
|
|
All Investments
Active
Investments
Exited
Investments |
 |
|
Cara Vita
Cara
Vita has developed a cost-effective, health maintenance approach to
caring for the chronically frail elderly in non skilled settings.
While principally a residential care provider, Cara Vita has integrated
private home health and day care programs into its facilities to provide
an alternative for those seniors and their families who are not yet
prepared for a residential program. Cara Vita is built on a care model
designed to enhance resident health and allow high acuity residents
to remain in Cara Vita's facilities longer and age in place gracefully.
Co-Investors: Delphi, Live Oak, Cordova
|
|
|
 |
|
Corus Pharma
Corus
Pharma, a Seattle-based specialty pharmaceutical development company,
is committed to developing and obtaining regulatory approvals of products
for respiratory and infectious diseases that can help provide improved
health and superior quality of life.
Co-Investors: MDS, Novo, JP Morgan
|
|
|
 |
|
Napo Pharmaceuticals (LSE: NAPL)
Napo Pharmaceuticals, Inc. is focused on developing and commercializing proprietary pharmaceuticals for the global marketplace, in collaboration with local partners, in order to address major global unmet medical needs in developed and developing countries. Napo is currently developing crofelemer, which is in various stages of clinical development for four distinct product indications, including one product in Phase III, two in Phase II and one in Phase I clinical trials.
Co-Investor: Vulcan
|
|
|
 |
|
National Healing
National
Healing is a disease management company with a focused expertise in
managing wound treatment centers inside client hospitals. The Company
has established 50 clinics with hospital clients including: Columbia,
Quorum, MedCath, and several independent hospitals. In their centers,
National Healing provides high-quality, cost-effective methodologies
to expedite the healing of wounds and reduce inpatient stays.
Co-Investors: Sole Institutional Investor |
|
|
|
|
|
|
|
|
|
